It was a daunting task to develop the first industry forum on thinking radically differently about the way we perform clinical trials, but the result was this conference. The event was launched in Philadelphia in September 2011 with 125 disruptive thinkers and change makers eager to discuss current solutions in clinical development, propose innovative changes, and commit to testing and sharing the results in order to transform drug development and the industry.
The first DPharm event addressed virtual clinical trial models, adaptive design thinking, the role of EHRs in clinical data, open source, telemedicine, and self-reported patient data among many other ideas. I remember Dr Tomasz Sablinski, Founder, Transparency Life Sciences saying it was the first event he had attended in a long time where he did not leave feeling depressed.
By the time the 2nd annual DPharm program took place, the concept of applying disruptive thinking to clinical development had taken root, with many attendees bearing titles with clinical innovation in them. Fast forward to 2014, the 4th annual program we ran in September in Boston, addressed numerous examples of innovative thinking to advance clinical trials ranging from collaborative trials, mobile companionship, digital engagement to design thinking, telemedicine and more.